These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The next generation of novel therapies for the management of relapsed multiple myeloma. Gonsalves WI; Milani P; Derudas D; Buadi FK Future Oncol; 2017 Jan; 13(1):63-75. PubMed ID: 27513456 [TBL] [Abstract][Full Text] [Related]
6. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Kumar S; Paiva B; Anderson KC; Durie B; Landgren O; Moreau P; Munshi N; Lonial S; Bladé J; Mateos MV; Dimopoulos M; Kastritis E; Boccadoro M; Orlowski R; Goldschmidt H; Spencer A; Hou J; Chng WJ; Usmani SZ; Zamagni E; Shimizu K; Jagannath S; Johnsen HE; Terpos E; Reiman A; Kyle RA; Sonneveld P; Richardson PG; McCarthy P; Ludwig H; Chen W; Cavo M; Harousseau JL; Lentzsch S; Hillengass J; Palumbo A; Orfao A; Rajkumar SV; Miguel JS; Avet-Loiseau H Lancet Oncol; 2016 Aug; 17(8):e328-e346. PubMed ID: 27511158 [TBL] [Abstract][Full Text] [Related]
7. Response evaluation and monitoring of multiple myeloma. Fernández de Larrea C; Delforge M; Davies F; Bladé J Expert Rev Hematol; 2014 Feb; 7(1):33-42. PubMed ID: 24483347 [TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma: is it time for biomarker-driven therapy? Bhutani M; Landgren O; Usmani SZ Am Soc Clin Oncol Educ Book; 2015; ():e493-503. PubMed ID: 25993214 [TBL] [Abstract][Full Text] [Related]
15. Role of new treatment approaches in defining treatment goals in multiple myeloma--the ultimate goal is extended survival. Durie BG Cancer Treat Rev; 2010 May; 36 Suppl 2():S18-23. PubMed ID: 20472184 [TBL] [Abstract][Full Text] [Related]
17. Advances in biology and therapy of multiple myeloma. Barillé-Nion S; Barlogie B; Bataille R; Bergsagel PL; Epstein J; Fenton RG; Jacobson J; Kuehl WM; Shaughnessy J; Tricot G Hematology Am Soc Hematol Educ Program; 2003; ():248-78. PubMed ID: 14633785 [TBL] [Abstract][Full Text] [Related]
18. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. Rajkumar SV; Harousseau JL; Durie B; Anderson KC; Dimopoulos M; Kyle R; Blade J; Richardson P; Orlowski R; Siegel D; Jagannath S; Facon T; Avet-Loiseau H; Lonial S; Palumbo A; Zonder J; Ludwig H; Vesole D; Sezer O; Munshi NC; San Miguel J; Blood; 2011 May; 117(18):4691-5. PubMed ID: 21292775 [TBL] [Abstract][Full Text] [Related]
19. Advances in the autologous and allogeneic transplantation strategies for multiple myeloma. Nishihori T; Alsina M Cancer Control; 2011 Oct; 18(4):258-67. PubMed ID: 21976244 [TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation. Rajkumar SV; Buadi F Best Pract Res Clin Haematol; 2007 Dec; 20(4):665-80. PubMed ID: 18070712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]